E-Naturals Plus 400 IU/50 mcg Softgel Capsule Filipines - anglès - FDA (Food And Drug Administration)

e-naturals plus 400 iu/50 mcg softgel capsule

lkn value plus corp.; distributor: lkn value plus corp. - d-alpha tocopheryl acetate (vitamin e) , selenium - softgel capsule - 400 iu/50 mcg

E-Naturals 400 IU Softgel Capsule Filipines - anglès - FDA (Food And Drug Administration)

e-naturals 400 iu softgel capsule

lkn value plus corp.; distributor: lkn value plus corp. - d-alpha tocopheryl acetate (vitamin e) - softgel capsule - 400 iu

HYZAAR- losartan potassium and hydrochlorothiazide tablet, film coated Estats Units - anglès - NLM (National Library of Medicine)

hyzaar- losartan potassium and hydrochlorothiazide tablet, film coated

rebel distributors corp - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - losartan potassium 100 mg - hyzaar is indicated for the treatment of hypertension. this fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients (see clinical pharmacology, pharmacodynamics and clinical effects, and dosage and administration). hyzaar is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race, clinical pharmacology, pharmacodynamics and clinical effects, losartan potassium, reduction in the risk of stroke,race, and dosage and administration.) hyzaar is contraindicated in patients who are hypersensitive to any component of this product. because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

LOSARTAN POTASSIUM tablet, film coated
LOSORTAN POTASSIUM- losartan potassium tablet, film coated Estats Units - anglès - NLM (National Library of Medicine)

losartan potassium tablet, film coated losortan potassium- losartan potassium tablet, film coated

mckesson corporation dba sky packaginng - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 25 mg - losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarction. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive

LOSARTAN POTASSIUM tablet, film coated Estats Units - anglès - NLM (National Library of Medicine)

losartan potassium tablet, film coated

mckesson corporation dba sky packaging - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 100 mg - losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarction. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE tablet Estats Units - anglès - NLM (National Library of Medicine)

losartan potassium and hydrochlorothiazide tablet

rebel distributors corp - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - losartan potassium 100 mg - hypertension      losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. this fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients (see clinical pharmacology, pharmacodynamics and clinical effects, and dosage and administration). hypertensive patients with left ventricular hypertrophy      losartan potassium and hydrochlorothiazide tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race, clinical pharmacology, pharmacodynamics and clinical effects, losartan potassium, reduction in the risk of stroke, race, and dosage and administration). losartan potassium and hydrochlorothiazide tablets are contraindicated in patie

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE tablet, film coated Estats Units - anglès - NLM (National Library of Medicine)

losartan potassium and hydrochlorothiazide tablet, film coated

rebel distributors corp - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - hydrochlorothiazide 25 mg - losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension. this fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients (see  clinical pharmacology , pharmacodynamics and clinical effects, and dosage and administration). losartan potassium and hydrochlorothiazide tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients (see precautions , race, clinical pharmacology , pharmacodynamics and clinical effects, losartan potassium, reduction in the risk of stroke, race, and dosage and administration). losartan potassium and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to any component of this product. because of the

Rosuzet 10 mg/5 mg Film-Coated Tablet Filipines - anglès - FDA (Food And Drug Administration)

rosuzet 10 mg/5 mg film-coated tablet

organon (philippines), incorporated - ezetimibe , rosuvastatin (as calcium) - film-coated tablet - 10 mg/5 mg

Rosuzet 10 mg/10 mg Film-Coated Tablet Filipines - anglès - FDA (Food And Drug Administration)

rosuzet 10 mg/10 mg film-coated tablet

organon (philippines), incorporated - ezetimibe , rosuvastatin (as calcium) - film-coated tablet - 10 mg/10 mg

Rosuzet 10 mg/20 mg Film-Coated Tablet Filipines - anglès - FDA (Food And Drug Administration)

rosuzet 10 mg/20 mg film-coated tablet

organon (philippines), incorporated - ezetimibe , rosuvastatin (as calcium) - film-coated tablet - 10 mg/20 mg